Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Tisagenlecleucel
3:52
Outcomes of children and young adults with B-ALL following tisa-cel reinfusion
Kevin McNerney
• 24 Feb 2023
5:36
Investigating real-world outcomes of patients with R/R LBCL after CD19 CAR-T cell therapy
Veit Buecklein
• 9 Dec 2022
1:22
Engineering NK cell-based cancer treatments
Juliane Mietz
• 1 Apr 2022
3:08
Accelerating commercialization in advanced therapies
Pascal Touchon
• 7 Apr 2021
3:39
An overview of the CAR T-cell therapy story
Mohamad Mohty
• 26 Jan 2021
4:14
Practical aspects of CAR T-cell therapy
Ulrich Jäger
• 9 Feb 2021
4:18
The challenges of CAR T-cell therapy for pediatric B-ALL
Sara Ghorashian
• 4 Feb 2021
2:16
Updates on CAR T-cell therapy in B-cell malignancies
Ulrich Jäger
• 9 Feb 2021
2:42
CAR-T therapy for aggressive B-cell lymphomas
Peter A. Riedell
• 2 Sep 2020
4:51
Anti-CD19 CAR T-cells for adults
David L. Porter
• 9 Sep 2020
3:05
Real-world efficacy & safety data: CAR-T in DLBCL
Matthew Frigault
• 1 Sep 2020
2:18
Tocilizumab: CAR T-cell therapy in DLBCL
Matthew Frigault
• 1 Sep 2020